Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin

Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of gastroenterology & hepatology 2010-01, Vol.22 (1), p.123-124
Hauptverfasser: Alavian, Seyed-Moayed, Tabatabaei, Seyed-Vahid
Format: Artikel
Sprache:eng
Schlagworte:
Anemia, Sickle Cell - complications
Antiviral Agents - therapeutic use
beta-Thalassemia - complications
Drug Therapy, Combination
Hepatitis C, Chronic - drug therapy
Humans
Interferons - therapeutic use
Ribavirin - therapeutic use
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 124
container_issue 1
container_start_page 123
container_title European journal of gastroenterology & hepatology
container_volume 22
creator Alavian, Seyed-Moayed
Tabatabaei, Seyed-Vahid
description
doi_str_mv 10.1097/MEG.0b013e32832e0a66
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734170100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734170100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3511-d7d493919fd13307e8e11685bfee3077c91d4248503e9d58e31940dbd7f7014f3</originalsourceid><addsrcrecordid>eNpdkE1r3DAQhkVJabZp_0EIuuXkZMaSLetYliQtJPSSQm9CtsZYjT-2kpwl_77aZiEQkBCC93lneBg7R7hC0Or64ebuClpAQaJsRElg6_oD26BUoqjqRp2wDehKFrXG36fsc4x_AFAJVJ_YKWpdaS3LDXt-DGTTRHPiy5q6ZSK-9LwbwjL7jg-0s8knH_mW-5lH3z2NxDsaR-58JBuJ29nxNNjRxkhTRg5Abot879OQoUShp9z2Pxh8a5998PMX9rG3Y6Svx_eM_bq9edx-L-5_3v3YfrsvOlEhFk45qYVG3TsUAhQ1hFg3VdsT5a_qNDpZyqYCQdpVDQnUElzrVK8AZS_O2OVr7y4sf1eKyUw-Hva3My1rNEpIzEmAnJSvyS4sMQbqzS74yYYXg2AOwk0Wbt4Lz9jFccDaTuTeoKPht979MmYX8Wlc9xTMQHZMgwEAWSqhivKwRD5Q5Fui-Acds43R</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734170100</pqid></control><display><type>article</type><title>Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Alavian, Seyed-Moayed ; Tabatabaei, Seyed-Vahid</creator><creatorcontrib>Alavian, Seyed-Moayed ; Tabatabaei, Seyed-Vahid</creatorcontrib><identifier>ISSN: 0954-691X</identifier><identifier>EISSN: 1473-5687</identifier><identifier>DOI: 10.1097/MEG.0b013e32832e0a66</identifier><identifier>PMID: 19959942</identifier><language>eng</language><publisher>England: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Anemia, Sickle Cell - complications ; Antiviral Agents - therapeutic use ; beta-Thalassemia - complications ; Drug Therapy, Combination ; Hepatitis C, Chronic - drug therapy ; Humans ; Interferons - therapeutic use ; Ribavirin - therapeutic use ; Treatment Outcome</subject><ispartof>European journal of gastroenterology &amp; hepatology, 2010-01, Vol.22 (1), p.123-124</ispartof><rights>2010 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3511-d7d493919fd13307e8e11685bfee3077c91d4248503e9d58e31940dbd7f7014f3</citedby><cites>FETCH-LOGICAL-c3511-d7d493919fd13307e8e11685bfee3077c91d4248503e9d58e31940dbd7f7014f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19959942$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alavian, Seyed-Moayed</creatorcontrib><creatorcontrib>Tabatabaei, Seyed-Vahid</creatorcontrib><title>Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin</title><title>European journal of gastroenterology &amp; hepatology</title><addtitle>Eur J Gastroenterol Hepatol</addtitle><subject>Anemia, Sickle Cell - complications</subject><subject>Antiviral Agents - therapeutic use</subject><subject>beta-Thalassemia - complications</subject><subject>Drug Therapy, Combination</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Humans</subject><subject>Interferons - therapeutic use</subject><subject>Ribavirin - therapeutic use</subject><subject>Treatment Outcome</subject><issn>0954-691X</issn><issn>1473-5687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE1r3DAQhkVJabZp_0EIuuXkZMaSLetYliQtJPSSQm9CtsZYjT-2kpwl_77aZiEQkBCC93lneBg7R7hC0Or64ebuClpAQaJsRElg6_oD26BUoqjqRp2wDehKFrXG36fsc4x_AFAJVJ_YKWpdaS3LDXt-DGTTRHPiy5q6ZSK-9LwbwjL7jg-0s8knH_mW-5lH3z2NxDsaR-58JBuJ29nxNNjRxkhTRg5Abot879OQoUShp9z2Pxh8a5998PMX9rG3Y6Svx_eM_bq9edx-L-5_3v3YfrsvOlEhFk45qYVG3TsUAhQ1hFg3VdsT5a_qNDpZyqYCQdpVDQnUElzrVK8AZS_O2OVr7y4sf1eKyUw-Hva3My1rNEpIzEmAnJSvyS4sMQbqzS74yYYXg2AOwk0Wbt4Lz9jFccDaTuTeoKPht979MmYX8Wlc9xTMQHZMgwEAWSqhivKwRD5Q5Fui-Acds43R</recordid><startdate>201001</startdate><enddate>201001</enddate><creator>Alavian, Seyed-Moayed</creator><creator>Tabatabaei, Seyed-Vahid</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201001</creationdate><title>Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin</title><author>Alavian, Seyed-Moayed ; Tabatabaei, Seyed-Vahid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3511-d7d493919fd13307e8e11685bfee3077c91d4248503e9d58e31940dbd7f7014f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anemia, Sickle Cell - complications</topic><topic>Antiviral Agents - therapeutic use</topic><topic>beta-Thalassemia - complications</topic><topic>Drug Therapy, Combination</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Humans</topic><topic>Interferons - therapeutic use</topic><topic>Ribavirin - therapeutic use</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alavian, Seyed-Moayed</creatorcontrib><creatorcontrib>Tabatabaei, Seyed-Vahid</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of gastroenterology &amp; hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alavian, Seyed-Moayed</au><au>Tabatabaei, Seyed-Vahid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin</atitle><jtitle>European journal of gastroenterology &amp; hepatology</jtitle><addtitle>Eur J Gastroenterol Hepatol</addtitle><date>2010-01</date><risdate>2010</risdate><volume>22</volume><issue>1</issue><spage>123</spage><epage>124</epage><pages>123-124</pages><issn>0954-691X</issn><eissn>1473-5687</eissn><cop>England</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>19959942</pmid><doi>10.1097/MEG.0b013e32832e0a66</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0954-691X
ispartof European journal of gastroenterology & hepatology, 2010-01, Vol.22 (1), p.123-124
issn 0954-691X
1473-5687
language eng
recordid cdi_proquest_miscellaneous_734170100
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Anemia, Sickle Cell - complications
Antiviral Agents - therapeutic use
beta-Thalassemia - complications
Drug Therapy, Combination
Hepatitis C, Chronic - drug therapy
Humans
Interferons - therapeutic use
Ribavirin - therapeutic use
Treatment Outcome
title Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T20%3A35%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20outcome%20of%20chronic%20hepatitis%20C%20in%20sickle%20cell%20disease%20and%20thalassemic%20patients%20with%20interferon%20and%20ribavirin&rft.jtitle=European%20journal%20of%20gastroenterology%20&%20hepatology&rft.au=Alavian,%20Seyed-Moayed&rft.date=2010-01&rft.volume=22&rft.issue=1&rft.spage=123&rft.epage=124&rft.pages=123-124&rft.issn=0954-691X&rft.eissn=1473-5687&rft_id=info:doi/10.1097/MEG.0b013e32832e0a66&rft_dat=%3Cproquest_cross%3E734170100%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734170100&rft_id=info:pmid/19959942&rfr_iscdi=true